Current Allergy and Asthma Reports

, Volume 13, Issue 5, pp 528–538 | Cite as

Non-Pharmacologic Therapies for Atopic Dermatitis



Atopic dermatitis (AD) continues to present significant therapeutic challenges, especially in severe cases. Navigating the line between risk and benefit can be difficult for more powerful medications such as immunosuppressants, but non-pharmacologic treatments are often overlooked and underutilized. Creative application of these more physical therapies can serve to minimize the pharmacologic treatments and their side effects, and possibly even create synergy between modalities, to maximize benefit to the patient.


Atopic dermatitis Therapy Non-pharmacologic Physical Eczema Cryotherapy Hydrotherapy Climate Temperature Balneotherapy Phytotherapy Moisturization Diet Nutrition 


Compliance with Ethics Guidelines

Conflict of Interest

Peter A. Lio has served on boards for Modernizing Medicine and the National Eczema Association, has served as a consultant for Johnson & Johnson & Merck & Co., and has received grant support from the Atopic Dermatitis Foundation.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci. 2013;70(1):3–11. doi: 10.1016/j.jdermsci.2013.02.001.Google Scholar
  2. 2.
    Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1980;92:44–7.Google Scholar
  3. 3.
    Bendsöe N, Björnberg A, Asnes H. Itching from wool fibres in atopic dermatitis. Contact Dermatitis. 1987;17:21–2.PubMedCrossRefGoogle Scholar
  4. 4.
    Ring J, Brockow K, Abeck D. The therapeutic concept of “patient management” in atopic eczema. Allergy. 1996;51:206–15.PubMedGoogle Scholar
  5. 5.
    Koller DY, Halmerbauer G, Böck A, Engstler G. Action of a silk fabric treated with AEGIS in children with atopic dermatitis: a 3-month trial. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2007;18:335–8.CrossRefGoogle Scholar
  6. 6.
    Ricci G, Patrizi A, Bendandi B, Menna G, Varotti E, Masi M. Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis. Br J Dermatol. 2004;150:127–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Senti G, Steinmann LS, Fischer B, Kurmann R, Storni T, Johansen P, et al. Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. Dermatology (Basel, Switzerland). 2006;213:228–33.CrossRefGoogle Scholar
  8. 8.
    Vlachou C, Thomas KS, Williams HC. A case report and critical appraisal of the literature on the use of DermaSilk in children with atopic dermatitis. Clin Exp Dermatol. 2009;34:e901–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Gauger A, Mempel M, Schekatz A, Schafer T, Ring J. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology (Basel, Switzerland). 2003;207:15–21.CrossRefGoogle Scholar
  10. 10.
    Gauger A, Fischer S, Mempel M, Schaefer T, Foelster-Holst R, Abeck D, et al. Efficacy and functionality of silver-coated textiles in patients with atopic eczema. J Eur Acad Dermatol Venereol JEADV. 2006;20:534–41.CrossRefGoogle Scholar
  11. 11.
    Juenger M, Ladwig A, Staecker S, Arnold A, Kramer A, Daeschlein G, et al. Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Curr Med Res Opin. 2006;22:739–50.PubMedCrossRefGoogle Scholar
  12. 12.
    Araújo CP, Gomes J, Vieira AP, Ventura F, Fernandes JC, Brito C. A proposal for the use of new silver-seaweed-cotton fibers in the treatment of atopic dermatitis. Cutan Ocul Toxicol. 2013. doi: 10.3109/15569527.2013.775655
  13. 13.
  14. 14.
  15. 15.
    Body Suit With Folding Gloves - Infant Eczema Treatment - Infants - DermaSilk,
  16. 16.
    Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol. 2013;133(7):1752–9. doi: 10.1038/jid.2013.19.Google Scholar
  17. 17.
    Langan SM, Bourke JF, Silcocks P, Williams HC. An exploratory prospective observational study of environmental factors exacerbating atopic eczema in children. Br J Dermatol. 2006;154:979–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Sargen MR, Hoffstad O, Margolis DJ. Warm, humid, and high sun exposure climates are associated with poorly controlled eczema: PEER (Pediatric Eczema Elective Registry) Cohort, 2004–2012. J Invest Dermatol. 2013. doi: 10.1038/jid.2013.274
  19. 19.
    Byremo G, Rød G, Carlsen KH. Effect of climatic change in children with atopic eczema. Allergy. 2006;61:1403–10.PubMedCrossRefGoogle Scholar
  20. 20.
    Klimenko T, Ahvenainen S, Karvonen S-L. Whole-body cryotherapy in atopic dermatitis. Arch Dermatol. 2008;144:806–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Lee KC, West D, Holbrook J, Kwasny M, Lio P. Novel use of a cooling pillow for treatment of severe head and neck atopic dermatitis. J Am Acad Dermatol. 2013;68:AB77.CrossRefGoogle Scholar
  22. 22.
    Matz H, Orion E, Wolf R. Balneotherapy in dermatology. Dermatol Ther. 2003;16:132–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Katz U, Shoenfeld Y, Zakin V, Sherer Y, Sukenik S. Scientific evidence of the therapeutic effects of dead sea treatments: a systematic review. Semin Arthritis Rheum. 2012;42(2):186–200. doi: 10.1016/j.semarthrit.2012.02.006.Google Scholar
  24. 24.
    Farina S, Gisondi P, Zanoni M, Pace M, Rizzoli L, Baldo E, et al. Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy. J Dermatol Treat. 2011;22:366–71.CrossRefGoogle Scholar
  25. 25.
    Taieb C, Sibaud V, Merial-Kieny C. Impact of Avène hydrotherapy on the quality of life of atopic and psoriatic patients. J Eur Acad Dermatol Venereol JEADV. 2011;25 Suppl 1:24–9.CrossRefGoogle Scholar
  26. 26.
    Casas C, Ribet V, Alvarez-Georges S, Sibaud V, Guerrero D, Schmitt A-M, et al. Modulation of Interleukin-8 and staphylococcal flora by Avène hydrotherapy in patients suffering from chronic inflammatory dermatoses. J Eur Acad Dermatol Venereol JEADV. 2011;25 Suppl 1:19–23.CrossRefGoogle Scholar
  27. 27.
    Castex-Rizzi N, Charveron M, Merial-Kieny C. Inhibition of TNF-alpha induced-adhesion molecules by Avène Thermal Spring Water in human endothelial cells. J Eur Acad Dermatol Venereol JEADV. 2011;25 Suppl 1:6–11.CrossRefGoogle Scholar
  28. 28.
    Adler-Cohen C, Czarnowicki T, Dreiher J, Ruzicka T, Ingber A, Harari M. Climatotherapy at the Dead Sea: an effective treatment modality for atopic dermatitis with significant positive impact on quality of life. Dermatitis. 2012;23:75–80.PubMedGoogle Scholar
  29. 29.
    Heinlin J, Schiffner-Rohe J, Schiffner R, Einsele-Krämer B, Landthaler M, Klein A, et al. A first prospective randomized controlled trial on the efficacy and safety of synchronous balneophototherapy vs. narrow-band UVB monotherapy for atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2011;25:765–73.CrossRefGoogle Scholar
  30. 30.
    Gambichler T, Küster W, Kreuter A, Altmeyer P, Hoffmann K. Balneophototherapy–combined treatment of psoriasis vulgaris and atopic dermatitis with salt water baths and artificial ultraviolet radiation. J Eur Acad Dermatol Venereol JEADV. 2000;14:425–8.CrossRefGoogle Scholar
  31. 31.
    Zimmermann J, Utermann S. Photo-brine therapy in patients with psoriasis and neurodermatitis atopica. Der Hautarzt. Z Dermatol Venerol verwandte Gebiete. 1994;45:849–53.CrossRefGoogle Scholar
  32. 32.
    Thomas KS, Dean T, O’Leary C, Sach TH, Koller K, Frost A, et al. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med. 2011;8:e1000395.PubMedCrossRefGoogle Scholar
  33. 33.
    Morison WL, Parrish JA, Fitzpatrick TB. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol. 1978;98:25–30.PubMedCrossRefGoogle Scholar
  34. 34.
    Walker D, Jacobe H. Phototherapy in the age of biologics. Semin Cutan Med Surg. 2011;30:190–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Bogh MKB, Gullstrand J, Svensson A, Ljunggren B, Dorkhan M. Narrowband ultraviolet B three times per week is more effective in treating vitamin D deficiency than 1600 IU oral vitamin D3 per day: a randomized clinical trial. Br J Dermatol. 2012;167:625–30.PubMedCrossRefGoogle Scholar
  36. 36.
    Sidbury R, Sullivan AF, Thadhani RI, Camargo CA. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159:245–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Gattringer C, Müller H, Steurer M, Steger C, Ratzinger G. Narrowband UVB therapy for the treatment of pruritus in hypereosinophilic syndrome: clinical report and review of the literature on phototherapy. J Am Acad Dermatol. 2012;67:e210–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Meduri NB, Vandergriff T, Rasmussen H, Jacobe H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed. 2007;23:106–12.PubMedCrossRefGoogle Scholar
  39. 39.
    Majoie IML, Oldhoff JM, Van Weelden H, Laaper-Ertmann M, Bousema MT, Sigurdsson V, et al. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol. 2009;60:77–84.PubMedCrossRefGoogle Scholar
  40. 40.
    Carrascosa J-M, Tapia G, Bielsa I, Fuente M-J, Ferrandiz C. Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples. J Cutan Pathol. 2007;34:769–76.PubMedCrossRefGoogle Scholar
  41. 41.
    Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149:582–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14(4):321–4.Google Scholar
  43. 43.
    Gelmetti C, Boralevi F, Seité S, Grimalt R, Humbert P, Luger T, et al. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient. Pediatr Dermatol. 2012;29:714–8. doi: 10.1111/j.1525-1470.2012.01817.x.Google Scholar
  44. 44.
    Weber TM, Kausch M, Rippke F, Schoelermann AM, Filbry AW. Treatment of xerosis with a topical formulation containing glyceryl glucoside, natural moisturizing factors, and ceramide. J Clin Aesthet Dermatol. 2012;5:29–39.PubMedGoogle Scholar
  45. 45.
    Shi VY, Tran K, Lio PA. A comparison of physicochemical properties of a selection of modern moisturizers: hydrophilic index and pH. J Drugs Dermatol JDD. 2012;11:633–6.Google Scholar
  46. 46.
    Chiang C, Eichenfield LF. Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis. Pediatr Dermatol. 2009;26:273–8. doi: 10.1111/j.1525-1470.2009.00911.x.
  47. 47.
    • Draelos ZD. New treatments for restoring impaired epidermal barrier permeability: skin barrier repair creams. Clin Dermatol. 2012;30(3):345–8. doi: 10.1016/j.clindermatol.2011.08.018. A thorough but concise overview of the new so-called barrier repair creams. Dr. Draelos lists the main ingredients used and has a nice discussion of the purpose and scientific rationale of each. She lists the specific names of most of the well-known creams which is very helpful in sorting them all out.
  48. 48.
    Miller DW, Koch SB, Yentzer BA, Clark AR, O’Neill JR, Fountain J, et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol JDD. 2011;10:531–7.Google Scholar
  49. 49.
    Moncrieff G, Cork M, Lawton S, Kokiet S, Daly C, Clark C. Use of emollients in dry-skin conditions: consensus statement. Clin Exp Dermatol. 2013;38:231–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Hon KL, Leung AKC, Barankin B. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol. 2013. doi: 10.1007/s40257-013-0033-9
  51. 51.
    Lee JH, Lee SJ, Kim D, Bang D. The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2007;21:1360–8.CrossRefGoogle Scholar
  52. 52.
    Devillers ACA, Oranje AP. Efficacy and safety of “wet-wrap” dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol. 2006;154:579–85.PubMedCrossRefGoogle Scholar
  53. 53.
    • Braham SJ, Pugashetti R, Koo J, Maibach HI. Occlusive therapy in atopic dermatitis: overview. J Dermatolog Treat. 2010;21:62–72. A well-written and very thorough look at occlusive treatments—both wet and dry—in AD treatment. The discussion features an especially nice piece on cutaneous and systemic side effects along with excellent practical tips.PubMedCrossRefGoogle Scholar
  54. 54.
    Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123:e808–14.PubMedCrossRefGoogle Scholar
  55. 55.
    Craig FE, Smith EV, Williams HC. Bleach baths to reduce severity of atopic dermatitis colonized by Staphylococcus. Arch Dermatol. 2010;146:541–3.PubMedCrossRefGoogle Scholar
  56. 56.
    Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol. 2010;163:12–26.PubMedCrossRefGoogle Scholar
  57. 57.
    Ryan C, Shaw RE, Cockerell CJ, Hand S, Ghali FE. Novel sodium hypochlorite cleanser shows clinical response and excellent acceptability in the treatment of atopic dermatitis. Pediatr Dermatol. 2013;30:308–15.PubMedCrossRefGoogle Scholar
  58. 58.
    Ersser SJ, Latter S, Sibley A, Satherley PA, Welbourne S. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2007;18(3). doi: 10.1002/14651858.CD004054.pub2.
  59. 59.
    Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther. 2003;16:114–22.PubMedCrossRefGoogle Scholar
  60. 60.
    King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res. 1991;35:697–706.PubMedCrossRefGoogle Scholar
  61. 61.
    Sokel B, Kent C, Lansdown R, Atherton D, Glover M, Knibbs J. A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemp Hypn. 1993(10).Google Scholar
  62. 62.
    Bae BG, Oh SH, Park CO, Noh S, Noh JY, Kim KR, et al. Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy. Acta Derm Venereol. 2012;92:57–61.PubMedCrossRefGoogle Scholar
  63. 63.
    Melin L, Frederiksen T, Noren P, Swebilius BG. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol. 1986;115:467–74.PubMedCrossRefGoogle Scholar
  64. 64.
    Weber MB, De Tarso Da Luz Fontes Neto P, Prati C, Soirefman M, Mazzotti NG, Barzenski B, et al. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol JEADV. 2008;22:992–7.CrossRefGoogle Scholar
  65. 65.
    Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB, Balkrishnan R, et al. Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J. 2008;14(13).Google Scholar
  66. 66.
    Krejci-Manwaring J, McCarty MA, Camacho F, Carroll CL, Johnson K, Manuel J, et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol. 2006;54:S235–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Stalder J-F, Bernier C, Ball A, De Raeve L, Gieler U, Deleuran M, et al. Therapeutic Patient Education in Atopic Dermatitis: Worldwide Experiences. Pediatr Dermatol. 2013;30:329–34.PubMedCrossRefGoogle Scholar
  68. 68.
    Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol. 2009;50:100–6.PubMedCrossRefGoogle Scholar
  69. 69.
    Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ (Clin Res ed). 2006;332(933–8).Google Scholar
  70. 70.
    Armstrong AW, Kim RH, Idriss NZ, Larsen LN, Lio PA. Online video improves clinical outcomes in adults with atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol. 2011;64:502–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Bostoen J, Bracke S, De Keyser S, Lambert J. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. Br J Dermatol. 2012;167:1025–31.PubMedCrossRefGoogle Scholar
  72. 72.
    Shi VY, Nanda S, Lee K, Armstrong AW, Lio PA. Improving patient education with an eczema action plan: a randomized controlled trial. JAMA Dermatol. 2013;149(4):481–3. doi: 10.1001/jamadermatol.2013.2143.Google Scholar
  73. 73.
    Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol. 2006;118:209–13.PubMedCrossRefGoogle Scholar
  74. 74.
    Flohr C, Johansson SGO, Wahlgren C-F, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol. 2004;114:150–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Roguedas-Contios A-M, Misery L. What is intrinsic atopic dermatitis? Clin Rev Allergy Immunol. 2011;41:233–6.PubMedCrossRefGoogle Scholar
  76. 76.
    Nakamura T, Hirasawa Y, Takai T, Mitsuishi K, Okuda M, Kato T, et al. Reduction of skin barrier function by proteolytic activity of a recombinant house dust mite major allergen Der f 1. J Invest Dermatol. 2006;126:2719–23.PubMedCrossRefGoogle Scholar
  77. 77.
    Jeong SK, Kim HJ, Youm J-K, Ahn SK, Choi EH, Sohn MH, et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol. 2008;128:1930–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E, et al. Atopic dermatitis, house-dust mite, and the placebo effect. Allergy. 2001;56:1226–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Chapman MD, Rowntree S, Mitchell EB, Di Prisco de Fuenmajor MC, Platts-Mills TA. Quantitative assessments of IgG and IgE antibodies to inhalant allergens in patients with atopic dermatitis. J Allergy Clin Immunol. 1983;72:27–33.PubMedCrossRefGoogle Scholar
  80. 80.
    Holm L, Bengtsson A, Van Hage-Hamsten M, Ohman S, Scheynius A. Effectiveness of occlusive bedding in the treatment of atopic dermatitis–a placebo-controlled trial of 12 months’ duration. Allergy. 2001;56:152–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E, et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol. 2001;145:70–4.PubMedCrossRefGoogle Scholar
  82. 82.
    Mochizuki H, Muramatsu R, Tadaki H, Mizuno T, Arakawa H, Morikawa A. Effects of skin care with shower therapy on children with atopic dermatitis in elementary schools. Pediatr Dermatol. 2009;26(2):223–5. doi: 10.1111/j.1525-1470.2009.00887.x.
  83. 83.
    Miyake Y, Ohya Y, Tanaka K, Yokoyama T, Sasaki S, Fukushima W, et al. Home environment and suspected atopic eczema in Japanese infants: the Osaka Maternal and Child Health Study. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2007;18:425–32.CrossRefGoogle Scholar
  84. 84.
    Endo K, Fukuzumi T, Adachi J, Kojima M, Aoki T, Yoshida M, et al. Effect of vacuum cleaning of room floors and bed clothes of patients on house dust mites counts and clinical scores of atopic dermatitis. A double blind control trial. Arerugī = Allergy. 1997;46:1013–24.Google Scholar
  85. 85.
    Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131:295–9.e1–27.Google Scholar
  86. 86.
    Bussmann C, Böckenhoff A, Henke H, Werfel T, Novak N. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol. 2006;118:1292–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Darsow U. Allergen-specific immunotherapy for atopic eczema: updated. Curr Opin Allergy Clin Immunol. 2012;12:665–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol. 2007;120:164–70.PubMedCrossRefGoogle Scholar
  89. 89.
    Gelmetti C. Diet and atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2000;14:439–40.CrossRefGoogle Scholar
  90. 90.
    Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics. 1998;101:E8.PubMedCrossRefGoogle Scholar
  91. 91.
    Thompson MM, Hanifin JM. Effective therapy of childhood atopic dermatitis allays food allergy concerns. J Am Acad Dermatol. 2005;53:S214–9.PubMedCrossRefGoogle Scholar
  92. 92.
    Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for improving established atopic eczema in adults and children: systematic review. Allergy. 2009;64:258–64.PubMedCrossRefGoogle Scholar
  93. 93.
    El-Chammas K, Danner E. Gluten-free diet in nonceliac disease. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr. 2011;26:294–9.CrossRefGoogle Scholar
  94. 94.
    Finn R, Harvey MM, Johnson PM, Verbov JL, Barnes RM. Serum IgG antibodies to gliadin and other dietary antigens in adults with atopic eczema. Clin Exp Dermatol. 1985;10:222–8.PubMedCrossRefGoogle Scholar
  95. 95.
    Ciacci C, Cavallaro R, Iovino P, Sabbatini F, Palumbo A, Amoruso D, et al. Allergy prevalence in adult celiac disease. J Allergy Clin Immunol. 2004;113:1199–203.PubMedCrossRefGoogle Scholar
  96. 96.
    Spence D. Bad medicine: food intolerance. BMJ (Clin Res ed). 2013;346(f529).Google Scholar
  97. 97.
    Boettcher E, Crowe SE. Dietary proteins and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:728–36.PubMedCrossRefGoogle Scholar
  98. 98.
    Alvares M, Kao L, Mittal V, Wuu A, Clark A, Bird JA. Misdiagnosed food allergy resulting in severe malnutrition in an infant. Pediatrics. 2013;132(1):e229–32. doi: 10.1542/peds.2012-2362.Google Scholar
  99. 99.
    Mutgi K, Koo J. Update on the role of systemic vitamin d in atopic dermatitis. Pediatr Dermatol. 2013;30:303–7.PubMedCrossRefGoogle Scholar
  100. 100.
    Lin Y-T, Wang C-T, Chiang B-L. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol. 2007;33:167–77.PubMedCrossRefGoogle Scholar
  101. 101.
    Oral Probiotics: An Introduction | NCCAM,
  102. 102.
    Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol. 2009;104:1033–49. quiz 1050.PubMedCrossRefGoogle Scholar
  103. 103.
    Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One. 2012;7:e34938.PubMedCrossRefGoogle Scholar
  104. 104.
    Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JNV, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA J Am Med Assoc. 2012;307:1959–69.CrossRefGoogle Scholar
  105. 105.
    Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076–9.PubMedCrossRefGoogle Scholar
  106. 106.
    Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child. 2005;90:892–7.PubMedCrossRefGoogle Scholar
  107. 107.
    Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850–6.PubMedCrossRefGoogle Scholar
  108. 108.
    Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355–60.PubMedCrossRefGoogle Scholar
  109. 109.
    Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach J-F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology (Cambridge, Mass). 2012;23:402–14.CrossRefGoogle Scholar
  110. 110.
    Van der Aa LB, Heymans HSA, Van Aalderen WMC, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2010;21:e355–67.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Clinical Dermatology & PediatricsNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations